Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Neumora Therapeutics, Inc. | 82,770 | reported | 17 Feb 2026 | tx 44+4,984,979−3,186,615 |
| Dermira, Inc. | 0 | reported | 20 Feb 2020 | tx 16+34,000−271,105 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 17 Feb 2026 | SALE | Neumora Therapeutics, Inc. | 6,165 | 3.56 USD | |
| 08 Jan 2026 | GRANT_AWARD | Neumora Therapeutics, Inc. | 750,000 | 0.00 USD | deriv |
| 11 Nov 2025 | SALE | Neumora Therapeutics, Inc. | 114,703 | 2.68 USD | |
| 28 May 2025 | GRANT_AWARD | Neumora Therapeutics, Inc. | 137,538 | — | deriv |
| 28 May 2025 | GRANT_AWARD | Neumora Therapeutics, Inc. | 40,890 | — | deriv |
| 28 May 2025 | OTHER | Neumora Therapeutics, Inc. | 1,000,000 | — | deriv |
| 28 May 2025 | OTHER | Neumora Therapeutics, Inc. | 195,000 | — | deriv |
| 28 May 2025 | OTHER | Neumora Therapeutics, Inc. | 29,737 | — | deriv |
| 28 May 2025 | OTHER | Neumora Therapeutics, Inc. | 72,221 | — | deriv |
| 28 May 2025 | OTHER | Neumora Therapeutics, Inc. | 136,210 | — | deriv |
| 28 May 2025 | OTHER | Neumora Therapeutics, Inc. | 207,901 | — | deriv |
| 28 May 2025 | OTHER | Neumora Therapeutics, Inc. | 137,538 | — | deriv |
| 28 May 2025 | OTHER | Neumora Therapeutics, Inc. | 40,890 | — | deriv |
| 28 May 2025 | GRANT_AWARD | Neumora Therapeutics, Inc. | 1,000,000 | — | deriv |
| 28 May 2025 | GRANT_AWARD | Neumora Therapeutics, Inc. | 195,000 | — | deriv |
| 28 May 2025 | GRANT_AWARD | Neumora Therapeutics, Inc. | 29,737 | — | deriv |
| 28 May 2025 | GRANT_AWARD | Neumora Therapeutics, Inc. | 72,221 | — | deriv |
| 28 May 2025 | GRANT_AWARD | Neumora Therapeutics, Inc. | 207,901 | — | deriv |
| 28 May 2025 | GRANT_AWARD | Neumora Therapeutics, Inc. | 136,210 | — | deriv |
| 18 Feb 2025 | SALE | Neumora Therapeutics, Inc. | 8,565 | 1.68 USD | |
| 13 Feb 2025 | GRANT_AWARD | Neumora Therapeutics, Inc. | 40,890 | — | deriv |
| 13 Feb 2025 | GRANT_AWARD | Neumora Therapeutics, Inc. | 137,538 | — | deriv |
| 13 Feb 2025 | OTHER | Neumora Therapeutics, Inc. | 195,000 | — | deriv |
| 13 Feb 2025 | OTHER | Neumora Therapeutics, Inc. | 29,737 | — | deriv |
| 13 Feb 2025 | OTHER | Neumora Therapeutics, Inc. | 72,221 | — | deriv |